1. Medtech Insight
  2. >>Business
  3. >>R&D

COVID-19 Fact File: Global Diagnostic Test Pipeline

 
• By Catherine Longworth

Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.

test tube of covid-19 and virus

As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.

In the US, the Food and Drug Administration has issued Emergency Use Authorizations (EUAs) to approve tests for the coronavirus. This allows temporary use of novel devices in emergency public...

On 12 March, Swiss group Roche Molecular Diagnostics was the first commercial developer to secure an EUA. (Also see "Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans...

More from R&D

More from Business

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By Shubham Singh

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.